Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration
- PMID: 17372907
- DOI: 10.1002/ijc.22679
Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration
Abstract
The c-Met receptor and its ligand scatter factor/hepatocyte growth factor (SF/HGF) are strongly overexpressed in malignant gliomas. Signaling through c-Met as well as exposure to hypoxia can stimulate glioma cell migration and invasion. In several cancer cell types, hypoxia was shown to activate the c-met promoter, which contains hypoxia inducible factor-1 (HIF-1) binding sites. We hypothesized that hypoxia might upregulate c-Met also in glioma cells. Analyzing 18 different glioblastoma cell lines and 10 glioblastoma primary cultures, we found that in 50% of both the cell lines and the primary cultures c-Met protein levels were increased following exposure to hypoxia. Upregulation of c-met in response to hypoxia was also detected at the transcriptional level. In all primary cultures and in 16 of the 18 cell lines (89%), HIF-1 alpha levels were increased by hypoxia. Transfection of siRNA against HIF-1 alpha abgrogated the hypoxic induction of c-Met, suggesting that c-Met expression is upregulated by a HIF-1 alpha-dependent mechanism. Hypoxia sensitized glioblastoma cell lines which showed hypoxic induction of c-Met to the motogenic effects of SF/HGF. These findings suggest that approximately half of all human glioblastomas respond to hypoxia with an induction of c-Met, which can enhance the stimulating effect of SF/HGF on tumor cell migration.
(c) 2007 Wiley-Liss, Inc.
Similar articles
-
Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.Int J Cancer. 2006 Dec 15;119(12):2750-9. doi: 10.1002/ijc.22178. Int J Cancer. 2006. PMID: 16998831
-
Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression.J Natl Cancer Inst. 1999 Sep 15;91(18):1548-56. doi: 10.1093/jnci/91.18.1548. J Natl Cancer Inst. 1999. PMID: 10491431
-
Met and hepatocyte growth factor/scatter factor expression in human gliomas.Cancer Res. 1997 Dec 1;57(23):5391-8. Cancer Res. 1997. PMID: 9393765
-
Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).Int J Mol Med. 1999 May;3(5):531-6. doi: 10.3892/ijmm.3.5.531. Int J Mol Med. 1999. PMID: 10202187 Review.
-
Targeting MET for glioma therapy.Neurosurg Focus. 2014 Dec;37(6):E10. doi: 10.3171/2014.9.FOCUS14520. Neurosurg Focus. 2014. PMID: 25434379 Review.
Cited by
-
Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited.Acta Neuropathol. 2012 Dec;124(6):763-75. doi: 10.1007/s00401-012-1066-5. Epub 2012 Nov 11. Acta Neuropathol. 2012. PMID: 23143192 Free PMC article. Review.
-
Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer management.Obstet Gynecol Int. 2010;2010:580971. doi: 10.1155/2010/580971. Epub 2010 Feb 14. Obstet Gynecol Int. 2010. PMID: 20169098 Free PMC article.
-
Diffuse glioma growth: a guerilla war.Acta Neuropathol. 2007 Nov;114(5):443-58. doi: 10.1007/s00401-007-0293-7. Epub 2007 Sep 6. Acta Neuropathol. 2007. PMID: 17805551 Free PMC article. Review.
-
The Vascular Microenvironment in Glioblastoma: A Comprehensive Review.Biomedicines. 2022 May 31;10(6):1285. doi: 10.3390/biomedicines10061285. Biomedicines. 2022. PMID: 35740307 Free PMC article. Review.
-
Biology of angiogenesis and invasion in glioma.Neurotherapeutics. 2009 Jul;6(3):447-57. doi: 10.1016/j.nurt.2009.04.001. Neurotherapeutics. 2009. PMID: 19560735 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous